These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7372548)

  • 21. Tobramycin: a review of its antibacterial and pharmacokinetic properties and therapeutic use.
    Brogden RN; Pinder RM; Sawyer PR; Speight TM; Avery GS
    Drugs; 1976; 12(3):166-200. PubMed ID: 789045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Susceptibilities of clinical isolates to aminoglycoside antibiotics. Susceptibility of clinical isolates from patients with complex and refractory infections].
    Deguchi K
    Jpn J Antibiot; 1982 Aug; 35(8):1977-86. PubMed ID: 7154245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of antibacterial activity of a new cephalosporin, ceftizoxime (FK 749) with other cephalosporin antibiotics.
    Nishida M; Kamimura T; Okada N; Matsumoto Y; Mine Y; Murakawa T; Goto S; Kuwahara S
    J Antibiot (Tokyo); 1979 Dec; 32(12):1319-27. PubMed ID: 317284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use.
    Noone P
    Drugs; 1984 Jun; 27(6):548-78. PubMed ID: 6376062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of fosfomycin tromethamine against extended spectrum beta-lactamase producing urinary tract bacteria.
    Khan IU; Mirza IA; Ikram A; Ali S; Hussain A; Ghafoor T
    J Coll Physicians Surg Pak; 2014 Dec; 24(12):914-7. PubMed ID: 25523727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1-N HAPA gentamicin B, a new aminoglycoside active against gentamicin resistant isolates--activity compared to other aminoglycosides.
    Neu HC; Fu KP
    J Antibiot (Tokyo); 1978 May; 31(5):385-93. PubMed ID: 27494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis.
    MacLeod DL; Barker LM; Sutherland JL; Moss SC; Gurgel JL; Kenney TF; Burns JL; Baker WR
    J Antimicrob Chemother; 2009 Oct; 64(4):829-36. PubMed ID: 19679597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of moxalactam against pathogenic bacteria and its comparison with other antibiotics.
    Perrymann F; Flournoy DJ; Qadri SM
    Chemotherapy; 1983; 29(1):37-42. PubMed ID: 6219865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antimicrobial activity of fosfomycin under various conditions against standard strains, beta-lactam resistant strains, and multidrug efflux system mutants].
    Mikuniya T; Hiraishi T; Maebashi K; Ida T; Takata T; Hikida M; Yamada S; Gotoh N; Nishino T
    Jpn J Antibiot; 2005 Apr; 58(2):105-22. PubMed ID: 15997654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An increase in the antimicrobial activity in vitro of fosfomycin under anaerobic conditions.
    Inouye S; Watanabe T; Tsuruoka T; Kitasato I
    J Antimicrob Chemother; 1989 Nov; 24(5):657-66. PubMed ID: 2599990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The in-vivo antibacterial activity of ceftazidime (Gr 20263)--a comparison with other new beta-lactam antibiotics and gentamicin.
    Acred P; Ryan DM; Sowa MA; Watts CM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():247-55. PubMed ID: 19802994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Gram-negative rods: antibacterial agents effective on gram-negative rods].
    Iyobe S
    Nihon Rinsho; 1994 Feb; 52(2):372-7. PubMed ID: 8126888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro investigations on the action fosfomycin alone and in combination with other antibiotics on Pseudomonas aeruginosa and Serratia marcescens.
    Ullmann U; Lindemann B
    Arzneimittelforschung; 1980; 30(8):1247-9. PubMed ID: 6776966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies.
    Falagas ME; Kastoris AC; Karageorgopoulos DE; Rafailidis PI
    Int J Antimicrob Agents; 2009 Aug; 34(2):111-20. PubMed ID: 19403273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The susceptibility to fosfomycin of Gram-negative bacteria isolates from urinary tract infection in the Czech Republic: data from a unicentric study.
    Fajfr M; Louda M; Paterová P; Ryšková L; Pacovský J; Košina J; Žemličková H; Broďák M
    BMC Urol; 2017 Apr; 17(1):33. PubMed ID: 28446177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo antimicrobial activities of sporaricin A, a new aminoglycoside.
    Kobayashi F; Saino Y; Koshi T; Hattori Y
    Antimicrob Agents Chemother; 1980 Mar; 17(3):337-43. PubMed ID: 7425599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycocinnamoylspermidines, a new class of antibiotics. V. Antibacterial evaluation of the isopropyl derivative of LL-BM123gamma.
    Kuck NA; Redin GS
    J Antibiot (Tokyo); 1978 May; 31(5):405-9. PubMed ID: 670083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo antibacterial activity of KW1070, a new aminoglycoside antibiotic.
    Ohashi Y; Kawabe H; Sato K; Nakamura N; Kurashige S; Mitsuhashi S
    Antimicrob Agents Chemother; 1980 Feb; 17(2):138-43. PubMed ID: 7387138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergy of fosmidomycin (FR-31564) and other antimicrobial agents.
    Neu HC; Kamimura T
    Antimicrob Agents Chemother; 1982 Oct; 22(4):560-3. PubMed ID: 7181471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibacterial activity of aztreonam: a synthetic monobactam. A comparative study with thirteen other antibiotics.
    Paradelis AG; Stathopoulos GA; Salpigides GN; Crassaris LG
    Methods Find Exp Clin Pharmacol; 1983; 5(6):375-83. PubMed ID: 6684718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.